Application 078252
- Type
- ANDA
- Sponsor
- INFORLIFE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | INJECTABLE;INJECTION | 200MG/100ML | No | No |
| 002 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | INJECTABLE;INJECTION | 400MG/200ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078252-001 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | 200MG/100ML | INJECTABLE / INJECTION | AP | 2008-03-18 | |
| A078252-002 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | CIPROFLOXACIN | 400MG/200ML | INJECTABLE / INJECTION | AP | 2008-03-18 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078252-001 | AP |
| A078252-002 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078252-001 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML | INJECTABLE / INJECTION | AP | 2008-03-18 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A078252-002 | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | 400MG/200ML | INJECTABLE / INJECTION | AP | 2008-03-18 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A078252-001 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A078252-002 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | ProPharma Distribution | 42c758be-4d44-018a-e063-6294a90ae041 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 078252 ANDA078252 |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | Hospira, Inc. | cbbbf939-3219-4515-a48e-ca264daa4d07 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 078252 ANDA078252 0409-2300 0409-3300 |
| Ciprofloxacin | CIPROFLOXACIN | Sagent Pharmaceuticals | f406e796-17d9-4465-b8a7-00d966a4ba74 | 2024-09-27 | Boxed warning, Warnings, Adverse reactions | 078252 ANDA078252 25021-192 |
| Ciprofloxacin | CIPROFLOXACIN | Sagent Pharmaceuticals | 7049f870-6741-4a67-8033-398c36126a06 | 2022-09-19 | Boxed warning, Warnings, Adverse reactions | 078252 ANDA078252 25021-114 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0409-2300 | Ciprofloxacin in Dextrose | ciprofloxacin | Hospira, Inc | ANDA | Current |
| 0409-3300 | Ciprofloxacin in Dextrose | ciprofloxacin | Hospira, Inc | ANDA | Current |
| 0781-3239 | Ciprofloxacin | Ciprofloxacin | Sandoz Inc | ANDA | Current |
| 0781-3240 | Ciprofloxacin | Ciprofloxacin | Sandoz Inc | ANDA | Current |
| 25021-114 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-114 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-114 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-114 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-114 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-192 | Ciprofloxacin | ciprofloxacin | Sagent Pharmaceuticals | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 31351 | ORIG | 2008-03-19 |